Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack D Bui

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi SarcomaErin G Reid, Kelly Shimabukuro, Page Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2014
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerHeinz Läubli, Oliver M T Pearce, Flavio Schwarz, et al.
Science Immunology|January 3, 2025
Functional differences between rodent and human PD-1 linked to evolutionary divergenceTakeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Evolutionary fingerprint in rodent PD1 confers weakened activity and enhanced tumor immunity compared to human PD1Takeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cellsVirginia Chu Cheung, Carly DaCosta, Jennifer Jaimez, et al.
The Journal of Experimental Medicine|August 29, 2012
Cancer immunoediting by the innate immune system in the absence of adaptive immunityTimothy O'Sullivan, Robert Saddawi-Konefka, William Vermi, et al.
Stem Cells (Dayton, Ohio)|April 18, 2026
Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cellsVirginia Chu Cheung, Jennifer Jaimez, Carly DaCosta, et al.
Cancer Research|February 7, 2019
Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase InhibitorYumi Yokoyama, Erin D Lew, Ruth Seelige, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
Increased Foxp3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsYi-Bin Chen, Yvonne A Efebera, Laura Johnston, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi SarcomaErin G Reid, Kelly Shimabukuro, Page Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2014
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancerHeinz Läubli, Oliver M T Pearce, Flavio Schwarz, et al.
Science Immunology|January 3, 2025
Functional differences between rodent and human PD-1 linked to evolutionary divergenceTakeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Evolutionary fingerprint in rodent PD1 confers weakened activity and enhanced tumor immunity compared to human PD1Takeya Masubuchi, Lin Chen, Nimi Marcel, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cellsVirginia Chu Cheung, Carly DaCosta, Jennifer Jaimez, et al.
The Journal of Experimental Medicine|August 29, 2012
Cancer immunoediting by the innate immune system in the absence of adaptive immunityTimothy O'Sullivan, Robert Saddawi-Konefka, William Vermi, et al.
Stem Cells (Dayton, Ohio)|April 18, 2026
Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cellsVirginia Chu Cheung, Jennifer Jaimez, Carly DaCosta, et al.
Cancer Research|February 7, 2019
Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase InhibitorYumi Yokoyama, Erin D Lew, Ruth Seelige, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
Increased Foxp3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsYi-Bin Chen, Yvonne A Efebera, Laura Johnston, et al.
Pageof 8